Abstract
Hypercholesterolemia and, more specifically, high circulating levels of LDL-cholesterol have been linked to several important diseases in man. For this reason, a concerted effort is now underway to develop effective strategies to decrease the concentration of this lipoprotein in the plasma. Over the last few years, new advances have been made in our understanding of the factors that control the plasma LDL-cholesterol concentration. It is now possible to predict the changes that will occur in the plasma LDL-cholesterol concentration given any change in LDL receptor number or affinity or in the LDL-cholesterol production rate. From an analysis of these kinetic relationships several important conclusions emerge. First, in both man and the experimental animal the rate of LDL-cholesterol production is the most significant determinant of the plasma LDL-cholesterol concentration. Second, receptor-dependent LDL-cholesterol degradation accounts for the majority of total LDL-cholesterol degradation in all species studied. Third, in quantitative terms, receptor-dependent LDL-cholesterol degradation is restricted to the liver and, to a lesser extent, the small intestine. It is also clear that in order to significantly change the plasma LDL-cholesterol concentration by altering the rate of receptor-dependent LDL-cholesterol clearance, a change in receptor number, rather than receptor affinity, must be made since the system is resistant to even large variations in receptor affinity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rudel, L. L., Parks, J. S., Johnson, F. L., Babiak, J. J.: Lipid Res. 27, 465 (1986)
Lipid Research Climes Program JAMA 251, 351 (1984)
Westergaard, H., Dietschy, J. M.: The uptake of lipids into the intestinal mucosa, in: Physiology of Membrane Disorders (eds.) Andreoli, T. E., Hoffman, J. F., Fanestil, D. D., Schultz, S. G., p. 597, New York, Plenum Publishing Corporation 1986.
Stange, E. F., Dietschy, J. M.: Cholesterol absorption and metabolism by the intestinal epithelium, in: Sterols and Bile Acids (eds.) Danielsson, H., Sjovall, J., p. 121, Amsterdam, Elsevier Science Publishers B.V. 1985
Sherrill, B. C., Dietschy, J. M.: J. Biol. Chem. 253, 1859 (1978)
Yamada, N., Shames, D. M., Stoudemire, J. B., Havel, R. J.: Proc. Natl. Acad. Sci. USA 83, 3479 (1986)
Spady, D. K., Bilheimer, D. W., Dietschy, J. M.: Proc. Natl. Acad. Sci. USA 80, 3499 (1983)
Brown, M. S., Goldstein, J. L.: Science 232, 34 (1986)
Spady, D. K., Turley, S. D., Dietschy, J. M.: J. Clin. Invest. 76, 1113 (1985)
Spady, D. K., Huettinger, M. L., Bilheimer, D. W., Dietschy, J. M.: J. Lipid Res. 28, 32 (1987)
Dietschy, J. M.: General principles governing movement of lipids across biological membranes, in: Disturbances in Lipid and Lipoprotein Metabolism (eds.) Dietschy, J. M., Gotto, A. M., Ontko, J. B., p. 1, Baltimore, Waverly Press, Inc. 1978.
Spady, D. K., Meddings, J. B., Dietschy, J. M.: J. Clin. Invest. 77, 1474 (1986)
Meddings, J. B., Dietschy, J. M.: Circulation 74, 805 (1986)
Bilheimer, D. W., Stone, N. J., Grundy, S. M.: J. Clin. Invest. 64, 524 (1979)
Grundy, S. M., Vega, G. L.: J. Lipid Res. 16, 1464 (1985)
Bilheimer, D. W., Grundy, S. M., Brown, M. S., Goldstein, J. L.: Proc. Natl. Acad. Sci. USA 80: 4124 (1983)
Spady, D. K., Dietschy, J. M.: Proc. Natl. Acad. Sci. USA 82, 4526 (1985)
Bilheimer, D. W., Goldstein, J. L., Grundy, S. M., Starzl, T. E., Brown, M. S.: N. EngL J. Med. 311, 1658 (1984)
Kovanen, P. T., Bilheimer, D. W., Goldstein, J. L., Haramillo, J. J., Brown, M. S.: Proc. Natl. Acad. Sci. USA 78, 1194 (1981)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Meddings, J.B., Dietschy, J.M. (1987). Regulation of Plasma Low Density Lipoprotein Levels: New Strategies for Drug Design. In: Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated Neutral Protease Microbial Iron Transport Pharmacokinetic Drug Interactions. Progress in Clinical Biochemistry and Medicine, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72902-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-72902-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72904-1
Online ISBN: 978-3-642-72902-7
eBook Packages: Springer Book Archive